Skip to main content
SpringerLink
Log in

Epidemiology and Risk Factors of Renal Cell Carcinoma

  • Chapter
  • First Online:
Diagnosis and Surgical Management of Renal Tumors

Abstract

Renal cell carcinoma (RCC) accounts for 2–3% of all adult malignant neoplasms. The incidence of RCC is increasing globally, with rates varying by country, age, race, and sex. Risk factors the development of RCC include cigarette smoking, obesity, hypertension, and industrial chemical exposure. In contrast, the consumption of fruit, vegtables and alcohol is associated with a decreased risk of RCC. In a minority of cases, the development of RCC is tied to hereditary syndromes. This chapter will discuss established and proposed risk factors for RCC. In addition, the available evidence and mechanisms associated with each risk factor will be reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Campbell SC, Lane BR. Malignant renal tumors. In: Wein AJ, Kavoussi LR, Partin AW, Peters CA, editors. Campbell-Walsh urology. 11th ed. Philadelphia: Elsevier; 2016. p. 1314–64.

    Google Scholar 

  2. Cairns P. Renal cell carcinoma. Cancer Biomark. 2011;9:461–73.

    Article  Google Scholar 

  3. Znaor A, Lortet-Tieulent J, Laversanne M, Jemal A, Bray F. International variations and trends in renal cell carcinoma incidence and mortality. Eur Urol. 2015;67(3):519–30.

    Article  Google Scholar 

  4. Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol. 2010;7(5):245–57. PMCID: 3012455.

    Article  Google Scholar 

  5. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30.

    Article  Google Scholar 

  6. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374–403.

    Article  CAS  Google Scholar 

  7. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.

    Article  CAS  Google Scholar 

  8. SEER stat fact sheets: kidney and renal pelvis. 2014 [updated 2014; cited]; Available from: https://seer.cancer.gov/statfacts/html/kidrp.html.

  9. Kane CJ, Mallin K, Ritchey J, Cooperberg MR, Carroll PR. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer. 2008;113(1):78–83.

    Article  Google Scholar 

  10. Decastro GJ, McKiernan JM. Epidemiology, clinical staging, and presentation of renal cell carcinoma. Urol Clin North Am. 2008;35(4):581–92; vi.

    Article  Google Scholar 

  11. Chow WH, Devesa SS. Contemporary epidemiology of renal cell cancer. Cancer J. 2008;14(5):288–301. PMCID: 3077538.

    Article  CAS  Google Scholar 

  12. Ljungberg B, Campbell SC, Choi HY, Jacqmin D, Lee JE, Weikert S, et al. The epidemiology of renal cell carcinoma. Eur Urol. 2011;60(4):615–21.

    Article  Google Scholar 

  13. Thompson RH, Ordonez MA, Iasonos A, Secin FP, Guillonneau B, Russo P, et al. Renal cell carcinoma in young and old patients--is there a difference? J Urol. 2008;180(4):1262–6; discussion 6. PMCID: 2615196.

    Article  Google Scholar 

  14. Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer. 1975;15(4):617–31.

    Article  CAS  Google Scholar 

  15. Food N. Physical activity, and the prevention of cancer: a global perspective. Washington, DC: American Institute for Cancer Research; 2007. Contract no.: document number|.

    Google Scholar 

  16. Bellocco R, Pasquali E, Rota M, Bagnardi V, Tramacere I, Scotti L, et al. Alcohol drinking and risk of renal cell carcinoma: results of a meta-analysis. Ann Oncol Off J Eur Soc Med Oncol. 2012;23(9):2235–44.

    Article  CAS  Google Scholar 

  17. Cumberbatch MG, Rota M, Catto JW, La Vecchia C. The role of tobacco smoke in bladder and kidney carcinogenesis: a comparison of exposures and meta-analysis of incidence and mortality risks. Eur Urol. 2016;70(3):458–66.

    Article  CAS  Google Scholar 

  18. Hunt JD, van der Hel OL, McMillan GP, Boffetta P, Brennan P. Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies. Int J Cancer. 2005;114(1):101–8.

    Article  CAS  Google Scholar 

  19. Parker AS, Cerhan JR, Janney CA, Lynch CF, Cantor KP. Smoking cessation and renal cell carcinoma. Ann Epidemiol. 2003;13(4):245–51.

    Article  Google Scholar 

  20. Lee JE, Mannisto S, Spiegelman D, Hunter DJ, Bernstein L, van den Brandt PA, et al. Intakes of fruit, vegetables, and carotenoids and renal cell cancer risk: a pooled analysis of 13 prospective studies. Cancer Epidemiol Biomark Prev. 2009;18(6):1730–9. PMCID: 2883186.

    Article  CAS  Google Scholar 

  21. Lee JE, Hunter DJ, Spiegelman D, Adami HO, Albanes D, Bernstein L, et al. Alcohol intake and renal cell cancer in a pooled analysis of 12 prospective studies. J Natl Cancer Inst. 2007;99(10):801–10.

    Article  Google Scholar 

  22. Lee JE, Giovannucci E, Smith-Warner SA, Spiegelman D, Willett WC, Curhan GC. Total fluid intake and use of individual beverages and risk of renal cell cancer in two large cohorts. Cancer Epidemiol Biomark Prev. 2006;15(6):1204–11.

    Article  Google Scholar 

  23. Hidayat K, Du X, Zou SY, Shi BM. Blood pressure and kidney cancer risk: meta-analysis of prospective studies. J Hypertens. 2017;35(7):1333–44.

    Article  CAS  Google Scholar 

  24. Weikert S, Boeing H, Pischon T, Weikert C, Olsen A, Tjonneland A, et al. Blood pressure and risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition. Am J Epidemiol. 2008;167(4):438–46.

    Article  Google Scholar 

  25. Purdue MP, Moore LE, Merino MJ, Boffetta P, Colt JS, Schwartz KL, et al. An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies. Int J Cancer. 2013;132(11):2640–7. PMCID: 3717609.

    Article  CAS  Google Scholar 

  26. McLaughlin JK, Lipworth L, Tarone RE. Epidemiologic aspects of renal cell carcinoma. Semin Oncol. 2006;33(5):527–33.

    Article  Google Scholar 

  27. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569–78.

    Article  Google Scholar 

  28. Adams KF, Leitzmann MF, Albanes D, Kipnis V, Moore SC, Schatzkin A, et al. Body size and renal cell cancer incidence in a large US cohort study. Am J Epidemiol. 2008;168(3):268–77. PMCID: 2727262.

    Article  Google Scholar 

  29. Chow WH, Gridley G, Fraumeni JF Jr, Jarvholm B. Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med. 2000;343(18):1305–11.

    Article  CAS  Google Scholar 

  30. Choi Y, Park B, Jeong BC, Seo SI, Jeon SS, Choi HY, et al. Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis. Int J Cancer. 2013;132(3):625–34.

    Article  CAS  Google Scholar 

  31. Hakimi AA, Furberg H, Zabor EC, Jacobsen A, Schultz N, Ciriello G, et al. An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma. J Natl Cancer Inst. 2013;105(24):1862–70. PMCID: 3866155.

    Article  CAS  Google Scholar 

  32. Chade AR, Lerman A, Lerman LO. Kidney in early atherosclerosis. Hypertension. 2005;45(6):1042–9.

    Article  CAS  Google Scholar 

  33. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4(8):579–91.

    Article  CAS  Google Scholar 

  34. Truong LD, Krishnan B, Cao JT, Barrios R, Suki WN. Renal neoplasm in acquired cystic kidney disease. Am J Kidney Dis. 1995;26(1):1–12.

    Article  CAS  Google Scholar 

  35. Marple JT, MacDougall M, Chonko AM. Renal cancer complicating acquired cystic kidney disease. J Am Soc Nephrol. 1994;4(12):1951–6.

    CAS  PubMed  Google Scholar 

  36. Srigley JR, Delahunt B, Eble JN, Egevad L, Epstein JI, Grignon D, et al. The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia. Am J Surg Pathol. 2013;37(10):1469–89.

    Article  Google Scholar 

  37. Ishikawa I, Yuri T, Kitada H, Shinoda A. Regression of acquired cystic disease of the kidney after successful renal transplantation. Am J Nephrol. 1983;3(6):310–4.

    Article  CAS  Google Scholar 

  38. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant. 2004;4(6):905–13.

    Article  Google Scholar 

  39. Denton MD, Magee CC, Ovuworie C, Mauiyyedi S, Pascual M, Colvin RB, et al. Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis. Kidney Int. 2002;61(6):2201–9.

    Article  Google Scholar 

  40. Cheungpasitporn W, Thongprayoon C, O’Corragain OA, Edmonds PJ, Ungprasert P, Kittanamongkolchai W, et al. The risk of kidney cancer in patients with kidney stones: a systematic review and meta-analysis. QJM. 2015;108(3):205–12.

    Article  CAS  Google Scholar 

  41. Parker AS, Cerhan JR, Lynch CF, Leibovich BC, Cantor KP. History of urinary tract infection and risk of renal cell carcinoma. Am J Epidemiol. 2004;159(1):42–8.

    Article  Google Scholar 

  42. Chow WH, Lindblad P, Gridley G, Nyren O, McLaughlin JK, Linet MS, et al. Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst. 1997;89(19):1453–7.

    Article  CAS  Google Scholar 

  43. Federico A, Morgillo F, Tuccillo C, Ciardiello F, Loguercio C. Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer. 2007;121(11):2381–6.

    Article  CAS  Google Scholar 

  44. Lindblad P, Chow WH, Chan J, Bergstrom A, Wolk A, Gridley G, et al. The role of diabetes mellitus in the aetiology of renal cell cancer. Diabetologia. 1999;42(1):107–12.

    Article  CAS  Google Scholar 

  45. Wideroff L, Gridley G, Mellemkjaer L, Chow WH, Linet M, Keehn S, et al. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst. 1997;89(18):1360–5.

    Article  CAS  Google Scholar 

  46. Zucchetto A, Dal Maso L, Tavani A, Montella M, Ramazzotti V, Talamini R, et al. History of treated hypertension and diabetes mellitus and risk of renal cell cancer. Ann Oncol: Off J Eur Soc Med Oncol. 2007;18(3):596–600.

    Article  CAS  Google Scholar 

  47. Gordon SC, Moonka D, Brown KA, Rogers C, Huang MA, Bhatt N, et al. Risk for renal cell carcinoma in chronic hepatitis C infection. Cancer Epidemiol Biomark Prev. 2010;19(4):1066–73.

    Article  CAS  Google Scholar 

  48. Hofmann JN, Torner A, Chow WH, Ye W, Purdue MP, Duberg AS. Risk of kidney cancer and chronic kidney disease in relation to hepatitis C virus infection: a nationwide register-based cohort study in Sweden. Eur J Cancer Prev. 2011;20(4):326–30. PMCID: 3104067.

    Article  Google Scholar 

  49. Gonzalez HC, Lamerato L, Rogers CG, Gordon SC. Chronic hepatitis C infection as a risk factor for renal cell carcinoma. Dig Dis Sci. 2015;60(6):1820–4.

    Article  CAS  Google Scholar 

  50. Wiwanitkit V. Renal cell carcinoma and hepatitis C virus infection: is there any cause-outcome relationship? J Cancer Res Ther. 2011;7(2):226–7.

    Article  Google Scholar 

  51. Mandel JS, McLaughlin JK, Schlehofer B, Mellemgaard A, Helmert U, Lindblad P, et al. International renal-cell cancer study. IV. Occupation. Int J Cancer. 1995;61(5):601–5.

    Article  CAS  Google Scholar 

  52. Cho E, Curhan G, Hankinson SE, Kantoff P, Atkins MB, Stampfer M, et al. Prospective evaluation of analgesic use and risk of renal cell cancer. Arch Intern Med. 2011;171(16):1487–93. PMCID: 3691864.

    Article  Google Scholar 

  53. Karami S, Daughtery SE, Schwartz K, Davis FG, Ruterbusch JJ, Wacholder S, et al. Analgesic use and risk of renal cell carcinoma: a case-control, cohort and meta-analytic assessment. Int J Cancer. 2016;139(3):584–92.

    Article  CAS  Google Scholar 

  54. Ruffin MT, Krishnan K, Rock CL, Normolle D, Vaerten MA, Peters-Golden M, et al. Suppression of human colorectal mucosal prostaglandins: determining the lowest effective aspirin dose. J Natl Cancer Inst. 1997;89(15):1152–60.

    Article  CAS  Google Scholar 

  55. Bessems JG, Vermeulen NP. Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches. Crit Rev Toxicol. 2001;31(1):55–138.

    Article  CAS  Google Scholar 

  56. Zbar B, Glenn G, Merino M, Middelton L, Peterson J, Toro J, et al. Familial renal carcinoma: clinical evaluation, clinical subtypes and risk of renal carcinoma development. J Urol. 2007;177(2):461–5; discussion 5.

    Article  Google Scholar 

  57. Coleman JA. Familial and hereditary renal cancer syndromes. Urol Clin North Am. 2008;35(4):563–72; v.

    Article  Google Scholar 

  58. Adeniran AJ, Shuch B, Humphrey PA. Hereditary renal cell carcinoma syndromes: clinical, pathologic, and genetic features. Am J Surg Pathol. 2015;39(12):e1–e18.

    Article  Google Scholar 

  59. Purdue MP, Johansson M, Zelenika D, Toro JR, Scelo G, Moore LE, et al. Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. Nat Genet. 2011;43(1):60–5. PMCID: 3049257.

    Article  CAS  Google Scholar 

  60. Machiela MJ, Hofmann JN, Carreras-Torres R, Brown KM, Johansson M, Wang Z, et al. Genetic variants related to longer telomere length are associated with increased risk of renal cell carcinoma. Eur Urol. 2017;72:747.

    Article  CAS  Google Scholar 

  61. Gnarra JR, Glenn GM, Latif F, Anglard P, Lerman MI, Zbar B, et al. Molecular genetic studies of sporadic and familial renal cell carcinoma. Urol Clin North Am. 1993;20(2):207–16.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Alexa R. Meyer, Mohamad E. Allaf & Michael A. Gorin

Authors
  1. Alexa R. Meyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohamad E. Allaf
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael A. Gorin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael A. Gorin .

Editor information

Editors and Affiliations

  1. The James Buchanan Brady Urological, Institute and Department of Urology, Johns Hopkins University School of Medic, Baltimore, MD, USA

    Michael A. Gorin

  2. The James Buchanan Brady Urological, Institute and Department of Urology, Johns Hopkins University School of Medic, Baltimore, MD, USA

    Mohamad E. Allaf

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Meyer, A.R., Allaf, M.E., Gorin, M.A. (2019). Epidemiology and Risk Factors of Renal Cell Carcinoma. In: Gorin, M., Allaf, M. (eds) Diagnosis and Surgical Management of Renal Tumors. Springer, Cham. https://doi.org/10.1007/978-3-319-92309-3_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-92309-3_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-92308-6

  • Online ISBN: 978-3-319-92309-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation